The European Commission and pharmaceutical policy
McKee, M.; Belcher, P.
Bmj 349: G5671
2014
ISSN/ISBN: 0959-8138 PMID: 25223390 Document Number: 674141
Document emailed within 1 workday
Related Documents
2002: Opinion on ethical aspects of patenting inventions involving human stem cells. The European Group on Ethics in Science and New Technologies to the European Commission. 7 May 2002 Revista de Derecho y Genoma Humano 2002(16): 266-271Commission of the European Communit, 2009: Communication From the Commission to the Council, the European Parliament, the European Economic and Social Committee, and the Committee of the Regions: A Mid-Term Assessment of Implementing the EC Biodiversity Action Plan Journal of International Wildlife Law and Policy 12(1-2): 108-120
1999: Table of cases relating to sexual and reproductive rights--European Commission on Human Rights and the European Court of Human Rights Medicine and Law 18(2-3): 447-450
1999: Table of cases relating to sexual and reproductive rights--European Commission on Human Rights and the European Court of Human Rights Medicine and Law 18(2-3): 447-450
Tousignaut, D.R. 1977: Joint Commission on Accreditation of Hospitals' 1977 standards for pharmaceutical services American Journal of Hospital Pharmacy 34(9): 943-950
Sjödin, C. 2008: The European Commission's comment on the compensation establishment is not sacred Lakartidningen 105(8): 556; Author Reply 556-7
Watson, R. 1999: European Commission's new president puts public health on the agenda Bmj 319(7204): 214
Tuffs, A. 2011: European Commission bans Egyptian seeds over E coli fears Bmj 343: D4436
Gottschewski, R. 1989: Changing interactions between the Common Agricultural Policy and other policy areas. Report on the annual colloquium of the Working Party on European Integration (AEI) from 10th- 11th November 1988 in Bonn Europaische Integration 16: 3-9
Watson, R. 2010: European Commission targets drug firms over illegal patent protection Bmj 340: C268
1971: Commission of the European Community prepares a program of action on the matter of environmental protection Minerva Medica 62(59-60 Suppl): 9-10
Int Comm Radiol Prot Comm 4 1973: Implications of commission recommendations that doses be kept as low as readily achievable a report of international commission of radiological protection committee 4 adopted by the commission in april 1973 Radiation Protection ICRP (International Commission on Radiological Protection) Publication 22: 1-18
Anklam, E. 2006: Selected papers from the European Commission mycotoxin sampling workshop, Brussels, Belgium, July 2004 Food Additives and Contaminants 23(1): 49-92
Zierenberg, O. 1997: Approval of drugs by national and European agencies--sequelae for the pharmaceutical industry Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 91(7): 596-600
2005: Council of the European Union publishes action list for Commission and member states to continue to fight HIV/AIDS in Europe and beyond Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles 10(6): E050630.5
Bedford, K. 2011: Care and the 53rd Commission on the Status of Women: a transformative policy space? Reproductive Health Matters 19(38): 197-207
Hakim, Z.; Kucukarslan, S. 1993: Regulation of biotechnology products in the global pharmaceutical market: the case of the European community and the United States Clinical Therapeutics 15(2): 442-458; Discussion 432
Berry, D.C.; Raynor, D.K.; Knapp, P.; Bersellini, E. 2003: Patients' understanding of risk associated with medication use: impact of European Commission guidelines and other risk scales Drug Safety 26(1): 1-11
Duckett, S.J. 2004: Drug policy down under: Australia's pharmaceutical benefits scheme Health Care Financing Review 25(3): 55-67
Watson, R. 2012: Environmental groups criticise European Commission's environmental record Bmj 345: E4691